nav.banner_textnav.banner_cta →
SwissNova Labs
Tesamorelin 10mg research vial
SwissNova Labs
Tesamorelin 10mg · 10mg
≥99% Purity · COA Included
Growth Hormone

Tesamorelin 10mg

Purity: 99%+
Size: 10mg
Grade: Research
Form: Lyophilized
✦
SwissNova Labs · Research Grade
Back to catalog
Growth HormoneNEW!

Tesamorelin 10mg

High-dose FDA-approved GHRH analog for visceral fat reduction and body composition optimization.

Visceral fat reduction — FDA-approved mechanism showing 15–18% VAT reduction in clinical trialsGH pulse preservation — stimulates natural pulsatile GH release without suppressing the hypothalamic-pituitary axisBody composition — reduces visceral fat while preserving lean muscle massCognitive support — emerging research shows improvements in executive function and memory via IGF-1 signaling
$95.00
10mg · Research use only
Compound Specifications
Purity99%+
Molecular Weight5135.8 Da
Vial Size10mg
SequenceTrans-3-hexenoic acid-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
Dosage Reference
Range1–2 mg
FrequencyDaily (before bed)
RouteSubcutaneous injection
Half-life26–38 minutes
Vial Supply
Duration~5 weeks supply
Week 1Week 5

2 mg/day (standard protocol)

Why Researchers Choose This Compound

Key Benefits

01
Visceral fat reduction

FDA-approved mechanism showing 15–18% VAT reduction in clinical trials

02
GH pulse preservation

stimulates natural pulsatile GH release without suppressing the hypothalamic-pituitary axis

03
Body composition

reduces visceral fat while preserving lean muscle mass

04
Cognitive support

emerging research shows improvements in executive function and memory via IGF-1 signaling

Administration Guide

Recommended Injection Sites

Optimal injection locations for Tesamorelin 10mg based on its route (Subcutaneous injection) and pharmacokinetic profile.

Tap a glowing zone on the body map to highlight the matching site card — or tap a card to activate the zone.

Site Map — front

Tap a zone to inject

Best
Good
Acceptable
Primary Sites
Abdomen
Best
Periumbilical fat (2 inches from navel)

Standard injection site for Tesamorelin. Rotate quadrants.

Thigh
Good
Anterolateral mid-thigh

Good alternative. Slightly slower absorption.

Secondary Sites
Deltoid
Acceptable
Lateral shoulder fat

Use shorter needle (5/16"). Requires assistance.

Needle Specs
Gauge27–29 gauge
Length5/16" – 1/2"
Angle45–90°
Site Rotation

Rotate injection sites to prevent lipodystrophy. Maintain ≥1 inch between injection points.

Avoid
  • IV administration
  • Intramuscular injection
  • Areas with active lipodystrophy
Mechanism of Action

Active Signaling Pathway

Supply Calculator

How long will one vial last?

Based on standard research protocols, here's exactly what to expect from a single 10mg vial — and when to plan your next order.

One vial lasts
5
weeks
That's approximately 1 month of continuous use at the standard protocol dose.
Reorder around week 4 to avoid running out
Your supply timeline10mg vial
Start↑ ReorderWeek 5 — empty
1
2
3
4
5
Active supplyReorder week
How we calculated this
10mg vial ÷ 2 mg/day (standard protocol) = 5 weeks of supply

Actual duration may vary based on your specific protocol. Always consult your research guidelines for precise dosing schedules.

Research Literature

Scientific Background

Mechanism of Action

Tesamorelin is a stabilized analog of endogenous GHRH with a trans-3-hexenoic acid group attached to the N-terminus, which protects it from dipeptidyl peptidase IV (DPP-IV) degradation and extends its half-life to 26–38 minutes. It binds to GHRH receptors on pituitary somatotrophs, triggering cAMP-mediated GH synthesis and pulsatile release. The resulting GH elevation stimulates hepatic IGF-1 production, which mediates the lipolytic effects on visceral fat.

Clinical Context

Tesamorelin has the strongest clinical evidence base of any GHRH analog, with multiple Phase III trials and FDA approval. Its visceral fat reduction effects are well-documented, and emerging research suggests cognitive benefits via IGF-1 signaling in the brain. The 10mg vial allows for extended protocols without frequent reordering.

Research Highlights

  • FDA-approved (2010) for HIV-associated lipodystrophy — one of the most rigorously studied GHRH analogs
  • Phase III trials showed 15–18% reduction in visceral adipose tissue (VAT) over 26 weeks
  • Demonstrated improvements in cognitive function (executive function, memory) in adults with mild cognitive impairment
  • Unlike direct GH, Tesamorelin preserves the natural GH feedback loop via somatostatin — no axis suppression

Storage & Reconstitution

PROTOCOL NOTE

Standard protocol: 2 mg/day SubQ. Reconstitute immediately before use — inject within 3 hours. 5/2 protocol (5 days on, 2 days off) also used.

RESEARCH USE ONLY:All products are sold strictly for in vitro research and laboratory use. Not intended for human consumption, clinical use, diagnosis, treatment, or prevention of any disease or condition. By purchasing, you confirm you are a qualified researcher and will use these compounds in accordance with all applicable laws and regulations.